NORTHERN TRUST CORP - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 40 filers reported holding REGULUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$50,000
+35.1%
168,172
+42.9%
0.00%
Q4 2021$37,000
-54.3%
117,6540.0%0.00%
Q3 2021$81,000
-15.6%
117,6540.0%0.00%
Q2 2021$96,000
-47.8%
117,6540.0%0.00%
Q1 2021$184,000
+247.2%
117,654
+198.4%
0.00%
Q4 2020$53,000
+140.9%
39,431
-7.7%
0.00%
Q3 2020$22,000
+37.5%
42,702
+77.8%
0.00%
Q2 2020$16,000
+128.6%
24,023
+53.8%
0.00%
Q1 2020$7,000
-50.0%
15,6210.0%0.00%
Q4 2019$14,000
+27.3%
15,6210.0%0.00%
Q3 2019$11,000
-42.1%
15,6210.0%0.00%
Q2 2019$19,000
+18.8%
15,6210.0%0.00%
Q1 2019$16,000
+14.3%
15,6210.0%0.00%
Q4 2018$14,00015,6210.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 1,985,472$3,097,0001.60%
Endurant Capital Management LP 2,376,557$3,707,0000.97%
Sarissa Capital Management LP 1,851,851$2,888,0000.28%
NEA Management Company, LLC 6,451,056$10,064,0000.23%
Atom Investors LP 337,228$526,0000.09%
Ikarian Capital, LLC 1,245,989$1,943,0000.06%
GYL FINANCIAL SYNERGIES, LLC 51,376$80,0000.04%
Focused Wealth Management, Inc 100,000$156,0000.03%
Point72 Asset Management, L.P. 3,215,436$5,016,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 141,629$221,0000.01%
View complete list of REGULUS THERAPEUTICS INC shareholders